Key result
Metabolic syndrome is a complex, multisystem disorder driven by chronic low-grade inflammation, mitochondrial dysfunction, and epigenetic factors, requiring novel biomarkers and personalized therapies.
This Special Issue editorial provides a comprehensive overview of emerging research on the multidimensional nature of metabolic syndrome, emphasizing novel biomarkers and therapeutic targets.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Procopciuc et al. (2026) conducted an editorial in Metabolic Syndrome. Metabolic syndrome is a complex, multisystem disorder driven by chronic low-grade inflammation, mitochondrial dysfunction, and epigenetic factors, requiring novel biomarkers and personalized therapies.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: